Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
about
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort studyObstructive sleep apnea syndrome and fatty liver: association or causal link?Almanac 2015: atrial fibrillation research in HeartResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisComorbidities and Metabolic Derangement of NAFLDNonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?Dietary habits and behaviors associated with nonalcoholic fatty liver diseaseCardiovascular dysfunction in patients with liver cirrhosisEctopic fat assessment focusing on cardiometabolic and renal riskNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature reviewSIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationHigh serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational studyγ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes StudyImpact of non-alcoholic fatty pancreas disease on glucose metabolism.Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis.Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.Fatty liver, carotid disease and gallstones: a study of age-related associationsNonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data.Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.Endpoints and clinical trial design for nonalcoholic steatohepatitis.Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors.Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopyNonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver diseaseThe association of vitamin D deficiency with non-alcoholic fatty liver disease.Links between ectopic fat and vascular disease in humansNonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesThrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in miceCardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver diseaseAssociation between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study.Current status of therapy in nonalcoholic Fatty liver disease.Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.
P2860
Q24596256-609A6CA6-5C3A-4510-8D22-3742877F4C47Q24612841-EA054AC2-75BF-43AF-9765-EA7073CF20FEQ26770598-A8D0185D-6A25-4E92-AE28-99B31FBC55BAQ26775340-6A246DA1-19DE-4B53-8241-2CCBEF48CBC6Q26777147-1638C1B3-D377-44D2-9B88-FE0F1A990B10Q26827169-D9C6ED67-F1E8-4613-8154-9073135B8FFDQ26830594-5B101F61-48E9-4984-BFCC-5779A82E10D4Q27010592-972D5739-C5DD-4A03-9045-6172FB65E22DQ27015940-2C30DB1C-AB33-4BB3-8D2C-86F8743A30FDQ27692035-0CCC5A97-791C-4596-A7E7-7F603CF53984Q28081066-3FC98DDF-DEBC-4CB6-BB81-371F806C4A08Q28275010-914EEE10-88F6-4AC5-A501-1BE41857FAACQ28474831-C30256DF-1BD0-44E7-8E8F-8E2A1E7352C2Q28648219-C3C33C5A-6304-4AB6-BCD1-A0C749AB37ABQ30234978-BF7547F0-FA7D-4000-92A2-BD2265A06DA7Q30274723-25ACC78F-70B7-49DE-92B1-8FACE176DD94Q30300233-AFF7102F-C125-41DD-8F90-2C14C90E1553Q30361645-894B0042-9BBD-4A30-8587-4D9B891FF644Q30410638-DC804A72-EE2A-4D9B-BDB6-EA8FD87D5BF3Q30433376-A2AD8D72-D852-4A2B-A9B1-BD844AFB27E5Q30622511-8B5478FF-CAD5-4B0D-92BC-D27536342997Q33375822-69846681-F2AF-4416-AAED-8F2000A9DD94Q33583798-FB75B027-110A-40D0-844B-88773D73A945Q33640536-5C2F0F5F-57DF-491B-959F-FDA43C32FE3DQ33693601-257D7C44-BF02-42BC-92A4-94181110595DQ33706798-FB2FDC0E-BBD7-4B01-8DDB-43BE4CBF2676Q33724815-0EFA9179-7C7E-4D3A-A622-31E199697FC3Q33797528-A6668F3D-53A4-4B84-9252-94011F458FBEQ33969464-7EC75BE2-88DD-40D6-9BDF-3E00C387AE04Q33984899-A2EE280C-E752-427C-A513-A22E8619DB29Q34031381-4276B29A-ABEF-422C-BF5C-C8FBCFF90626Q34076155-A9EBC600-C27D-4268-9277-7A55702B7CE3Q34099171-0CCBD2E2-C2D6-4FF2-B727-D9F74C0A3000Q34205386-9E5DF85C-BA1A-4862-880A-0C4AEA8B24FAQ34360710-ED4BB56C-87DA-47AF-9F24-593650B501FBQ34378263-1A7A5E31-3DC9-4A24-A2F0-B0CA52440127Q34406289-45F7020A-2B8E-4B9E-90B5-9B14F8743220Q34408961-6B64E0BA-F75B-4EC8-9401-775F706EC244Q34510307-F3F0957D-7747-46D1-8E0C-1AA855742E67Q34574104-71D017D4-C9C0-4D34-AE9E-86DAB8957D61
P2860
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nonalcoholic fatty liver disea ...... mong type 2 diabetic patients.
@en
type
label
Nonalcoholic fatty liver disea ...... mong type 2 diabetic patients.
@en
prefLabel
Nonalcoholic fatty liver disea ...... mong type 2 diabetic patients.
@en
P2093
P1433
P1476
Nonalcoholic fatty liver disea ...... mong type 2 diabetic patients.
@en
P2093
Felice Poli
Giancarlo Falezza
Giovanni Targher
Lorenzo Bertolini
Luca Scala
Luciano Zenari
Roberto Tessari
Stefano Rodella
P304
P356
10.2337/DIABETES.54.12.3541
P407
P577
2005-12-01T00:00:00Z